. 2024 Jun 6;13(3):e240076. doi: 10.1530/ETJ-24-0076
This work is licensed under a Table 2.
Cytologic–histologic distribution in the intervals 2006–2009, 2012–2014, and 2017–2019. Data are presented as n or as n (%).
| 2006–2009 | 2012–2014 | 2017–2019 | ||||||
|---|---|---|---|---|---|---|---|---|
| FP | FP atypia | III | IV | V | III | IV | V | |
| Malignant histology, n | 1 | 11 | 9 | 7 | 10 | 6 | 19 | 18 |
| PTC | 1 (100) | 8 (72.7) | 8 (88.9) | 0 | 18 (90) | 5 (83.3) | 13 (68.4) | 16 (88.8) |
| FTC | 0 | 2 (18.2) | 1 (11.1) | 5 (71.4) | 0 | 1 (16.7) | 3 (15.8) | 1 (5.6) |
| Oncocytic carcinoma | 0 | 1 (9.1) | 0 | 2 (28.6) | 0 | 0 | 2 (10.5) | 1 (5.6) |
| MTC | 0 | 0 | 0 | 0 | 2 (10) | 0 | 1 (5.3) | 0 |
| Benign histology, n | 29 | 45 | 35 | 9 | 3 | 11 | 50 | 5 |
| Hyperplastic nodule | 7 (24.1) | 16 (35.6) | 16 (45.7) | 4 (44.4) | 4 (33.3) | 7 (63.6) | 25 (50) | 1 (20) |
| Follicular adenoma | 18 (62.2) | 15 (33.3) | 15 (42.9) | 4 (44.4) | 4 (33.3) | 3 (27.3) | 17 (34) | 3 (60) |
| Oncocytic adenoma | 1 (3.4) | 8 (17.8) | 0 | 1 (11.2) | 1 (33.4) | 0 | 5 (10) | 0 |
| Hashimoto’s thyroiditis | 3 (10.3) | 6 (13.3) | 4 (11.4) | 0 | 0 | 1 (9.1) | 3 (6) | 1 (20) |
FP, follicular proliferation; FTC, follicular thyroid carcinoma; MTC, medullary thyroid carcinoma; PTC, papillary thyroid carcinoma.